In:
Frontiers in Public Health, Frontiers Media SA, Vol. 10 ( 2022-11-10)
Abstract:
Cardiovascular diseases (CVDs) continue to be the leading cause of death worldwide. Over the past couple of years and with the surge of the COVID-19 pandemic, mortality from CVDs has been slightly overshadowed by those due to COVID-19, although it was during the peak of the pandemic. In the present study, patients with CVDs (CVDs; n = 41,883) were analyzed to determine which comorbidities had the largest impact on overall patient mortality due to their association with both diseases ( n = 3,637). Obesity, hypertension, and diabetes worsen health in patients diagnosed positive for COVID-19. Hence, they were included in the overview of all patients with CVD. Our findings showed that 1,697 deaths were attributable to diabetes ( p & lt; 0.001) and 987 deaths to obesity ( p & lt; 0.001). Lastly, 2,499 deaths were attributable to hypertension ( p & lt; 0.001). Using logistic regression modeling, we found that diabetes (OR: 1.744, p & lt; 0.001) and hypertension (OR: 2.179, p & lt; 0.001) significantly affected the mortality rate of patients. Hence, having a CVD diagnosis, with hypertension and/or diabetes, seems to increase the likelihood of complications, leading to death in patients diagnosed positive for COVID-19.
Type of Medium:
Online Resource
ISSN:
2296-2565
DOI:
10.3389/fpubh.2022.1008565
DOI:
10.3389/fpubh.2022.1008565.s001
DOI:
10.3389/fpubh.2022.1008565.s002
DOI:
10.3389/fpubh.2022.1008565.s003
Language:
Unknown
Publisher:
Frontiers Media SA
Publication Date:
2022
detail.hit.zdb_id:
2711781-9
Permalink